PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institutet, Stockholm, Sweden.\', \'Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA.\', \'Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.\', \'Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.\', \'Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.\', \'Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.\', \'Division of Infection and Immunity, Cardiff University School of Medicine, University Hospital of Wales, Cardiff, UK.\', \'Systems Immunity Research Institute, Cardiff University School of Medicine, University Hospital of Wales, Cardiff, UK.\', \'Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California, San Diego, La Jolla, CA, USA.\', \'Infectious Diseases and Dermatology Unit, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.\', \'Department of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institutet, Stockholm, Sweden. marcus.buggert@ki.se.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41591-022-01700-x
?:hasPublicationType
?:journal
  • Nature medicine
is ?:pmid of
?:pmid
?:pmid
  • 35042228
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 17.067
?:rankingScore_hIndex
  • 484
is ?:relation_isRelatedTo_publication of
?:title
  • Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all